Company Overview of Hybritech, Inc.
Hybritech, Inc., a biotechnology company, develops, and markets monoclonal antibodies which are used in making diagnostic and medical monitoring tests to identify a variety of infectious, viral and cancer-related diseases including colon and prostate cancer, infertility, allergies, and pregnancy. The company was founded in 1978 and is based in San Diego, California. Hybritech, Inc. operates as a subsidiary of Beckman Coulter, Inc.
PO Box 269006
San Diego, CA 92196-9006
Founded in 1978
Key Executives for Hybritech, Inc.
Hybritech, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|BioQuanta Corp.||United States|
|Heliae Development, LLC||United States|
|NEONC Technologies, Inc.||United States|
|Adjuvance Technologies, Inc.||United States|
|Cerco Medical, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- St Louis, MO | Nova BiomedicalPosted: Apr 07
- Hyattsville, MD | University of Maryland University CollegePosted: Mar 26
- San Francisco, CA | Investment Firm Providing Private and Institutional BrokeragePosted: Apr 07
- Kansas City, MO | SkillsniperPosted: Apr 14
Sponsored Financial Commentaries
To contact Hybritech, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.